What people are saying about this resource:

This is extremely high yield, while also being short and digestible. I often need to supervise APPs and I will be sharing this guide with them as a concise summary of considerations when prescribing these first line medications.  In particular, I love the section "prescribing reminders and recommendations".  There are so many high yield points here that are extremely important to review when choosing these agents, and it is nice to have them all in one place.

MCT2D Clinician Decision Aid: SGLT-2 Inhibitor / GLP-1 RA for Type 2 Diabetes

DOWNLOAD RESOURCE

Updated: 07/23/24

SGLT2 inhibitors and GLP-1 receptor agonists are first-line treatments for T2D in patients with cardiorenal disease. This aid is meant to be used alongside your own clinical judgment, guideline-directed therapy, and prescribing information to guide individualization of diabetes treatment.
Lead clinical author is Heidi Diez, PharmD, clinical pharmacist, with Michael Heung, MD, nephrologist.

Tags: For Providers, Point-of-care, Created By MCT2D

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org